GS
Therapeutic Areas
Elthera Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anti-L1CAM Antibody Program | Aggressive malignancies (unspecified cancer types) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Anti-L1CAM Antibody Program | Aggressive malignancies (unspecified cancer types) | Pre-clinical |